| Literature DB >> 26984476 |
Sandra Kozak1, Lukas Lercher2,3, Megha N Karanth2,3, Rob Meijers1, Teresa Carlomagno4,5,6, Stephane Boivin7.
Abstract
Maintaining a stable fold for recombinant proteins is challenging, especially when working with highly purified and concentrated samples at temperatures >20 °C. Therefore, it is worthwhile to screen for different buffer components that can stabilize protein samples. Thermal shift assays or ThermoFluor(®) provide a high-throughput screening method to assess the thermal stability of a sample under several conditions simultaneously. Here, we describe a thermal shift assay that is designed to optimize conditions for nuclear magnetic resonance studies, which typically require stable samples at high concentration and ambient (or higher) temperature. We demonstrate that for two challenging proteins, the multicomponent screen helped to identify ingredients that increased protein stability, leading to clear improvements in the quality of the spectra. Thermal shift assays provide an economic and time-efficient method to find optimal conditions for NMR structural studies.Entities:
Keywords: Differential scanning fluorimetry; Nuclear magnetic resonance; Protein thermal stability; Sample optimization; Thermal shift assay; ThermoFluor
Mesh:
Substances:
Year: 2016 PMID: 26984476 PMCID: PMC4869703 DOI: 10.1007/s10858-016-0027-z
Source DB: PubMed Journal: J Biomol NMR ISSN: 0925-2738 Impact factor: 2.835
Fig. 1Description of the ThermoFluor screen platform workflow of the SPC facility at EMBL-Hamburg. The SPC facility hosts a platform to design and prepare an optimized screen for ThermoFluor, which includes (1) a web interface to design the screen composition remotely, (2) a liquid handling robot for the automated formulation of the screen, and (3) a data analysis interface
Fig. 2Optimization of sample conditions using the ThermoFluor screen improved NMR spectrum quality. a A ThermoFluor screen designed to perform protein profiling by thermal shift assay using a matrix-based approach. b Comparison of the 1H–13C-methyl TROESY spectra of RTT109 recorded before (left) and after (right) optimization. The inset shows representative melting curves in the corresponding buffer (E10; 50 mM sodium phosphate pH 7.0, 200 mM NaCl, D6; 50 mM sodium citrate pH 5.5, 200 mM NaCl). A complete description of the screen composition is available in supplementary Fig. S1 and the corresponding Tm values are displayed in Fig. S2. 1 mM DTT was added to the NMR samples in both buffers to prevent oxidation of exposed cysteines
Fig. 3Optimizing protein solubility for NMR studies. A comparison of the 1H–15N correlations of the BA protein in the initial buffer conditions (upper panel 50 mM potassium phosphate pH 7.0, 50 mM NaCl) and in the optimized buffer conditions (lower panel 50 mM potassium phosphate pH 7.5, 250 mM NaCl, 50 mM arginine, 0.5 mM TCEP). The maximum protein concentration that could be reached in the initial buffer did not exceed 3 mg/ml, while in the optimized conditions the protein could be concentrated to 9 mg/ml
Fig. 4Protein long-term stability. a Average of the intensity ratios at Day 1 and Day 10 for each peak in the 1H–13C-methyl TROESY spectrum of Rtt109 in the initial buffer (Phos) and in the optimized buffer (Cit). Both samples show only a modest intensity loss. b Gel page of Rtt109 after 10 Days in the initial (Phos) and optimized (Cit) buffer. Digestion of Rtt109 in the initial buffer is evident. c Average of the intensity ratios at Day 1 and Day 10 for each peak in the 1H–15N-TROESY spectrum of BA in the optimized buffer. No intensity loss is observed